Bliss GVS Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bliss GVS Pharma has submitted a routine quarterly certificate to NSE and BSE from its Registrar and Share Transfer Agent, MUFG Intime India (formerly Link Intime), under SEBI Regulation 74(5) of the Depositories and Participants Regulations, 2018, for the quarter ended June 30, 2025. The certificate confirms that all share certificates received for dematerialization during the quarter were properly accepted or rejected and reported to the depositories. Physical certificates received for demat were mutilated and cancelled after verification, and the depositories' names were substituted as registered owners in the company's member register within SEBI's prescribed timelines. Filed by the Company Secretary on July 4, 2025. This is a standard procedural filing required of all listed companies each quarter.
No material impact on shareholders or the stock price. This is a routine administrative compliance filing with no financial, strategic, or governance significance.